Bone Marrow TransplantationBone MarrowTransplantation, HomologousBone Marrow CellsGraft vs Host DiseaseTransplantation, AutologousGraft SurvivalWhole-Body IrradiationBone and BonesHematopoietic Stem Cell TransplantationAnemia, AplasticTransplantation ConditioningLiver TransplantationLeukemiaTransplantation ChimeraTissue DonorsBusulfanBone Marrow PurgingHematopoietic Stem CellsHistocompatibility TestingHistocompatibilityKidney TransplantationCyclophosphamideTransplantation, IsogeneicBone Marrow DiseasesHematopoiesisTime FactorsRecurrenceMice, Inbred C57BLTreatment OutcomeCombined Modality TherapyT-LymphocytesImmunosuppressive AgentsRadiation ChimeraLeukemia, Myelogenous, Chronic, BCR-ABL PositiveLeukemia, Myeloid, AcuteBone Marrow ExaminationHematologic NeoplasmsRemission InductionGraft RejectionTransplantation ImmunologyPrecursor Cell Lymphoblastic Leukemia-LymphomaGraft vs Host ReactionImmunosuppressionBone RemodelingHepatic Veno-Occlusive DiseaseLeukemia, MyeloidLymphocyte DepletionBone Marrow NeoplasmsAcute DiseaseHeart TransplantationStem Cell TransplantationLymphoma, Non-HodgkinLeukocyte TransfusionColony-Forming Units AssayRetrospective StudiesLeukocytes, MononuclearFlow CytometryHLA AntigensChimeraLeukocyte CountSurvival AnalysisSevere Combined ImmunodeficiencyCells, CulturedMyelodysplastic SyndromesCyclosporineLung TransplantationLymphocyte TransfusionPeripheral Blood Stem Cell TransplantationGranulocyte Colony-Stimulating FactorLymphocytesCell DifferentiationFollow-Up StudiesHematologic DiseasesBlood CellsAntineoplastic Combined Chemotherapy ProtocolsActuarial AnalysisBone DensitySpleenAntigens, CD34Nuclear FamilyOrgan TransplantationCarmustineSurvival RateImmunophenotypingPancytopeniaMice, Inbred BALB CCytomegalovirus InfectionsGraft vs Tumor EffectCytarabineGraft vs Leukemia EffectMelphalanMultiple MyelomaLymphomaLymphocyte ActivationCell SeparationAntibodies, MonoclonalDisease-Free SurvivalAntigens, CDBone Resorption